TSPAN10

gene
On this page

Also known as OCSP

Summary

TSPAN10 (tetraspanin 10, HGNC:29942) is a protein-coding gene on chromosome 17q25.3, encoding Tetraspanin-10 (Q9H1Z9). Part of TspanC8 subgroup, composed of 6 members that interact with the transmembrane metalloprotease ADAM10.

Enables enzyme binding activity. Involved in establishment of protein localization to organelle. Predicted to be located in membrane. Predicted to be active in plasma membrane.

Source: NCBI Gene 83882 — RefSeq curated summary.

At a glance

  • GWAS associations: 13
  • Clinical variants (ClinVar): 53 total
  • MANE Select transcript: NM_001290212

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:29942
Approved symbolTSPAN10
Nametetraspanin 10
Location17q25.3
Locus typegene with protein product
StatusApproved
AliasesOCSP
Ensembl geneENSG00000182612
Ensembl biotypeprotein_coding
Entrez83882

Gene structure

Transcript identifiers

Ensembl transcripts: 9 — 6 protein_coding, 1 retained_intron, 1 protein_coding_CDS_not_defined, 1 nonsense_mediated_decay

ENST00000571707, ENST00000571914, ENST00000611590, ENST00000621293, ENST00000696047, ENST00000696048, ENST00000869738, ENST00000869739, ENST00000869740

RefSeq mRNA: 2 — MANE Select: NM_001290212 NM_001290212, NM_031945

CCDS: CCDS58608

Canonical transcript exons

ENST00000611590 — 4 exons

ExonStartEnd
ENSE000036531758164499281645629
ENSE000037148718164790181648749
ENSE000037497388164230781642448
ENSE000039658908163719681637406

Expression profiles

Bgee: expression breadth ubiquitous, 160 present calls, max score 98.95.

FANTOM5 (CAGE): breadth broad, TPM avg 6.1663 / max 410.9174, expressed in 571 samples.

FANTOM5 promoters (2 alternative TSS)

Promoter IDTPM avgSamples expressed
1633453.2422370
1633442.9241468

Top tissues by expression

236 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
pigmented layer of retinaUBERON:000178298.95gold quality
kidney epitheliumUBERON:000481994.48gold quality
cardiac muscle of right atriumUBERON:000337991.55gold quality
left ventricle myocardiumUBERON:000656691.50gold quality
myocardiumUBERON:000234988.09gold quality
upper arm skinUBERON:000426387.65gold quality
vena cavaUBERON:000408786.35gold quality
epithelial cell of pancreasCL:000008385.93gold quality
gingival epitheliumUBERON:000194982.42silver quality
gingivaUBERON:000182881.90silver quality
skeletal muscle tissue of rectus abdominisUBERON:000451181.90gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047380.78gold quality
nasal cavity epitheliumUBERON:000538479.28gold quality
vastus lateralisUBERON:000137978.67gold quality
pericardiumUBERON:000240777.87gold quality
pharyngeal mucosaUBERON:000035577.83gold quality
quadriceps femorisUBERON:000137777.46gold quality
subthalamic nucleusUBERON:000190677.28gold quality
cardia of stomachUBERON:000116277.08gold quality
saphenous veinUBERON:000731877.01gold quality
dorsal plus ventral thalamusUBERON:000189776.82gold quality
ponsUBERON:000098876.78gold quality
inferior vagus X ganglionUBERON:000536376.75gold quality
layer of synovial tissueUBERON:000761676.71gold quality
buccal mucosa cellCL:000233676.61silver quality
tracheaUBERON:000312676.22gold quality
nippleUBERON:000203076.21silver quality
skeletal muscle tissue of biceps brachiiUBERON:000450276.16gold quality
pylorusUBERON:000116676.08gold quality
substantia nigra pars reticulataUBERON:000196676.07gold quality

Single-cell (SCXA)

Detected in 2 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-CURD-135yes1199.42
E-ANND-3no0.00

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

11 targeting TSPAN10, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-6851-5P100.0065.631294
HSA-MIR-127599.4767.902749
HSA-MIR-396099.4166.1196
HSA-MIR-465199.0667.572002
HSA-MIR-60898.9367.832013
HSA-MIR-6846-5P98.8165.861121
HSA-MIR-6848-5P98.8165.491126
HSA-MIR-807298.2766.2483
HSA-MIR-10400-5P96.9166.0056
HSA-MIR-446796.5164.4469
HSA-MIR-10392-3P88.7961.83122

Literature-anchored findings (GeneRIF, showing 1)

  • Genetic variant within the TSPAN10 gene is associated with strabismus. (PMID:31073882)

Cross-species orthologs

3 orthologs

OrganismSymbolGene ID
danio_reriotspan10ENSDARG00000044767
mus_musculusTspan10ENSMUSG00000039691
rattus_norvegicusTspan10ENSRNOG00000046076

Paralogs (32): TSPAN6 (ENSG00000000003), CD9 (ENSG00000010278), TSPAN9 (ENSG00000011105), TSPAN17 (ENSG00000048140), TSPAN32 (ENSG00000064201), CD82 (ENSG00000085117), TSPAN15 (ENSG00000099282), CD37 (ENSG00000104894), UPK1A (ENSG00000105668), TSPAN12 (ENSG00000106025), TSPAN13 (ENSG00000106537), TSPAN14 (ENSG00000108219), CD81 (ENSG00000110651), TSPAN11 (ENSG00000110900), PRPH2 (ENSG00000112619), UPK1B (ENSG00000114638), TSPAN1 (ENSG00000117472), TSPAN8 (ENSG00000127324), TSPAN16 (ENSG00000130167), TSPAN2 (ENSG00000134198), CD63 (ENSG00000135404), TSPAN31 (ENSG00000135452), TSPAN3 (ENSG00000140391), CD53 (ENSG00000143119), ROM1 (ENSG00000149489), TSPAN7 (ENSG00000156298), TSPAN18 (ENSG00000157570), TSPAN33 (ENSG00000158457), TSPAN5 (ENSG00000168785), CD151 (ENSG00000177697), TSPAN4 (ENSG00000214063), TSPAN19 (ENSG00000231738)

Protein

Protein identifiers

Tetraspanin-10Q9H1Z9 (reviewed: Q9H1Z9)

Alternative names: Oculospanin

All UniProt accessions (2): A0A087X235, Q6PJ65

UniProt curated annotations — full annotation on UniProt →

Function. Part of TspanC8 subgroup, composed of 6 members that interact with the transmembrane metalloprotease ADAM10. This interaction is required for ADAM10 exit from the endoplasmic reticulum and for enzymatic maturation and trafficking to the cell surface as well as substrate specificity. Different TspanC8/ADAM10 complexes have distinct substrates.

Subunit / interactions. Interacts with ADAM10.

Subcellular location. Cell membrane.

Tissue specificity. Expressed in the eye, including iris, ciliary body, retinal pigment epithelium, but not lens (protein level).

Similarity. Belongs to the tetraspanin (TM4SF) family.

RefSeq proteins (2): NP_001277141, NP_114151 (=MANE)

Domains & families (InterPro)

IDNameType
IPR008952Tetraspanin_EC2_sfHomologous_superfamily
IPR018499Tetraspanin/PeripherinFamily
IPR018503Tetraspanin_CSConserved_site

Pfam: PF00335

UniProt features (25 total): topological domain 5, sequence conflict 5, disulfide bond 4, transmembrane region 4, region of interest 2, sequence variant 2, chain 1, compositionally biased region 1, glycosylation site 1

Structure

Experimental structures (PDB)

1 structures.

PDBMethodResolution (Å)
9HV7X-RAY DIFFRACTION1.55

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q9H1Z9-F177.710.58

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Disulfide bonds (4): 212–279, 213–243, 229–237, 244–258

Glycosylation sites (1): 228

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 39 (showing top): GOBP_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_ORGANELLE, NIKOLSKY_BREAST_CANCER_17Q21_Q25_AMPLICON, CEBPZ_TARGET_GENES, CIITA_TARGET_GENES, GLI4_TARGET_GENES, KAT2A_TARGET_GENES, ZFP3_TARGET_GENES, ZNF146_TARGET_GENES, ZNF7_TARGET_GENES, ZNF711_TARGET_GENES, ZNF85_TARGET_GENES, ZSCAN30_TARGET_GENES, GSE17721_CTRL_VS_POLYIC_8H_BMDC_DN, HU_FETAL_RETINA_RPE, DESCARTES_MAIN_FETAL_RETINAL_PIGMENT_CELLS

GO Biological Process (1): establishment of protein localization to organelle (GO:0072594)

GO Molecular Function (1): enzyme binding (GO:0019899)

GO Cellular Component (2): plasma membrane (GO:0005886), membrane (GO:0016020)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
establishment of protein localization1
protein binding1
membrane1
cell periphery1
cellular anatomical structure1

Protein interactions and networks

STRING

756 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
TSPAN10NPLOC4Q8TAT6699
TSPAN10RAD51BO15315524
TSPAN10LRIT1Q9P2V4494
TSPAN10FIZ1Q96SL8482
TSPAN10CD81P18582474
TSPAN10CD9P21926473
TSPAN10RD3LP0DJH9467
TSPAN10TSPAN14Q8NG11434
TSPAN10B3GLCTQ6Y288431
TSPAN10PILRBQ9UKJ0431
TSPAN10ADAM10O14672425
TSPAN10ARMS2P0C7Q2419
TSPAN10TSPAN32Q96QS1413
TSPAN10TSPAN9O75954408
TSPAN10TSPAN12O95859408

IntAct

16 interactions, top by confidence:

ABTypeScore
HSD17B13TSPAN10psi-mi:“MI:0915”(physical association)0.590
ADGRG5KLRG2psi-mi:“MI:0914”(association)0.530
ADAM10TSPAN10psi-mi:“MI:0915”(physical association)0.400
LHFPL1TSPAN10psi-mi:“MI:0915”(physical association)0.400
PNLDC1C1QL1psi-mi:“MI:0914”(association)0.350
TSPAN10KLRG2psi-mi:“MI:0914”(association)0.350
OR6T1PSMD11psi-mi:“MI:0914”(association)0.350
SLC26A6SLC25A17psi-mi:“MI:0914”(association)0.350
OR52B2PCCApsi-mi:“MI:0914”(association)0.350
PTX3OFD1psi-mi:“MI:0914”(association)0.350
SLC12A9PGRMC1psi-mi:“MI:0914”(association)0.350
SLC44A1UPK3BL1psi-mi:“MI:0914”(association)0.350
TP53PPM1Gpsi-mi:“MI:0914”(association)0.350

BioGRID (77): ADAM10 (Affinity Capture-Western), TSPAN10 (Affinity Capture-MS), TSPAN10 (Affinity Capture-MS), TSPAN10 (Affinity Capture-MS), TSPAN10 (Affinity Capture-MS), TSPAN10 (Affinity Capture-RNA), TSPAN10 (Affinity Capture-MS), TSPAN10 (Affinity Capture-MS), TSPAN10 (Affinity Capture-MS), TSPAN10 (Affinity Capture-MS), TSPAN10 (Affinity Capture-MS), TSPAN10 (Proximity Label-MS), TSPAN10 (Affinity Capture-MS), FITM2 (Affinity Capture-MS), FAM134C (Affinity Capture-MS)

ESM2 similar proteins: A6NGC4, A6NKX4, A6NM10, F1NZP5, O96011, P0C242, P27544, P27545, Q0VCY6, Q2TBI8, Q3SYU3, Q4V8E5, Q5F2F2, Q5JZQ7, Q5RFI0, Q5U2T1, Q5U419, Q6AYM9, Q6GQT6, Q6PIS1, Q6TCG5, Q6UXD7, Q6UXT9, Q71RH2, Q7TNV1, Q7Z403, Q80ZE4, Q863Y8, Q86WI3, Q8BMT9, Q8CHK3, Q8IU68, Q8IXF9, Q8N9H8, Q8TBR7, Q8VC26, Q8WUG5, Q96N66, Q99640, Q99JT6

Diamond homologs: A0A8M2B5N2, A0A8V0ZLT4, A1L157, B5X3I6, O43657, O60635, O60636, O70352, O95859, O97703, P19075, P19397, P21926, P24485, P27701, P28648, P30409, P30932, P31053, P35762, P40237, P40239, P40240, P40241, P41731, P60033, P60034, P61170, P61171, P62079, P62080, Q17QJ5, Q29RH7, Q2KHY8, Q2KIS9, Q3SYV5, Q3T0S3, Q3ZBH3, Q3ZCD0, Q4R7W6

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

53 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance44
Likely benign4
Benign2

Top pathogenic / likely-pathogenic (0)

SpliceAI

658 predictions. Top by Δscore:

VariantEffectΔscore
17:81637301:G:GTdonor_gain0.9900
17:81637403:ACAGG:Adonor_loss0.9900
17:81637407:G:GAdonor_loss0.9900
17:81637407:G:GGdonor_gain0.9900
17:81645627:CCT:Cdonor_gain0.9900
17:81645630:G:GGdonor_gain0.9900
17:81637404:CAG:Cdonor_gain0.9800
17:81645182:TC:Tdonor_gain0.9800
17:81645625:AACCT:Adonor_gain0.9800
17:81645626:ACCT:Adonor_gain0.9800
17:81637405:AG:Adonor_gain0.9700
17:81637406:GG:Gdonor_gain0.9700
17:81637408:T:Gdonor_loss0.9700
17:81645281:G:Tdonor_gain0.9700
17:81645626:ACCTG:Adonor_loss0.9700
17:81645627:CCTGT:Cdonor_loss0.9700
17:81645628:CT:Cdonor_gain0.9700
17:81645628:CTG:Cdonor_loss0.9700
17:81645629:TGTGA:Tdonor_loss0.9700
17:81645630:GT:Gdonor_loss0.9700
17:81645631:T:Adonor_loss0.9700
17:81645632:G:GCdonor_loss0.9700
17:81637288:A:Tdonor_gain0.9600
17:81645121:GCCT:Gdonor_gain0.9600
17:81645281:G:GTdonor_gain0.9600
17:81645613:G:GTdonor_gain0.9600
17:81645633:A:ATdonor_loss0.9600
17:81645634:G:Cdonor_loss0.9600
17:81647896:TGCA:Tacceptor_loss0.9600
17:81647897:GCA:Gacceptor_loss0.9600

AlphaMissense

2235 scored. Top likely-pathogenic:

dbSNP variants (sampled 300 via entrez): RS1000126252 (17:81645382 C>T), RS1000202766 (17:81637097 G>A), RS1000327775 (17:81645694 C>T), RS1000803042 (17:81637984 T>C), RS1000867415 (17:81639185 G>A), RS1000915233 (17:81636480 T>C), RS1000944261 (17:81644229 C>G,T), RS1001079004 (17:81640867 T>C), RS1001173218 (17:81638251 A>G), RS1001430225 (17:81641110 A>T), RS1001671386 (17:81640252 G>A), RS1001782775 (17:81635212 G>A), RS1001981653 (17:81635404 G>A), RS1002450586 (17:81644668 G>A), RS1002575476 (17:81644878 C>T)

Disease associations

OMIM: gene `` | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

13 associations (top):

StudyTraitp-value
GCST003219_14Advanced age-related macular degeneration2.000000e-11
GCST003997_35Myopia2.000000e-18
GCST005580_29Intraocular pressure2.000000e-13
GCST006291_89Spherical equivalent or myopia (age of diagnosis)3.000000e-09
GCST006976_1Macular thickness1.000000e-118
GCST006986_12Red vs. brown/black hair color3.000000e-21
GCST006989_54Brown vs. black hair color8.000000e-70
GCST007157_9Corneal astigmatism8.000000e-09
GCST007159_31Corneal astigmatism2.000000e-13
GCST007486_24Hair morphology traits2.000000e-09
GCST007486_4Hair morphology traits1.000000e-08
GCST009474_2Central retinal vein equivalent4.000000e-09
GCST010002_133Refractive error2.000000e-50

EFO canonical traits (6, from GWAS)

EFO IDTrait name
EFO:1001492atrophic macular degeneration
EFO:0004695intraocular pressure measurement
EFO:0004847age at onset
EFO:0003924hair color
EFO:1002040Corneal astigmatism
EFO:0010554retinal vasculature measurement

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

29 total (human), top 29 by PubMed support.

ChemicalActions (top 5)PubMed papers
Cisplatinaffects cotreatment, increases expression2
Valproic Acidaffects cotreatment, increases expression, increases methylation2
Particulate Matterdecreases expression, increases expression2
afuresertibincreases expression1
FR900359affects phosphorylation1
propionaldehydeincreases expression1
sodium arsenatedecreases expression, increases abundance1
o,p’-DDTincreases expression1
sodium arseniteincreases expression1
butyraldehydeincreases expression1
benzo(e)pyrenedecreases methylation1
ferrous chloridedecreases expression1
CGP 52608increases reaction, affects binding1
AM 251increases expression1
nutlin 3affects cotreatment, increases expression1
jinfukangincreases expression, affects cotreatment1
Arsenicincreases abundance, decreases expression1
Atrazineincreases expression1
Benzo(a)pyreneaffects methylation1
Dactinomycinaffects cotreatment, increases expression1
Estradioldecreases expression1
Hydralazineaffects cotreatment, increases expression1
Methapyrilenedecreases methylation1
Mustard Gasincreases expression1
Smokedecreases expression1
Tobacco Smoke Pollutiondecreases expression1
Zearalenonedecreases expression1
Cadmium Chlorideincreases expression1
beta-Naphthoflavonedecreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

  • Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): wet macular degeneration